NETEC Resource Library

Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine — Preliminary Report

Item

Click for External Resource*


Click to read full article*


*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.


Item Type

Publication

Terms of Use

By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.

Share this page:

Was this resource helpful?


Title

Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine — Preliminary Report

Subject

Description

The mRNA-1273 vaccine against SARS-CoV-2 elicited high neutralizing-antibody titers in phase 1 trial participants and has been shown to be highly efficacious in preventing symptomatic Covid-19 disease and severe disease.

Date

2021-02-17

Citation

Wu, Kai, Anne P. Werner, Matthew Koch, Angela Choi, Elisabeth Narayanan, Guillaume B. E. Stewart-Jones, Tonya Colpitts, Hamilton Bennett, Seyhan Boyoglu-Barnum, Wei Shi, Juan I. Moliva, Nancy J. Sullivan, Barney S. Graham, Andrea Carfi, Kizzmekia S. Corbett, Robert A. Seder, and Darin K. Edwards. 2021. "Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine — Preliminary Report." New England Journal of Medicine.

Accessibility

Free online on NEJM.

Collection